Clinical Trial Update: Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 pilot study evaluated imatinib mesylate (Gleevec) in patients with neurofibromatosis type 1 and plexiform neurofibromas; the trial completed and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: Kent Robertson | Conditions: Neurofibromatosis, Neurofibromas | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-02